Centene (CNC) · Health Insurance
Centene Q2 2026 earnings: summary, key numbers & outlook
Results filed 28 Jul 2026 · Quarter ended 30 Jun 2026
Press release ↗Investor relations ↗
Summaries and transcripts are machine-generated and can contain errors.
In brief
Centene is narrowing its Medicare Advantage footprint toward dual-eligible members while D-SNP members reach about 40% of that portfolio, as it works to restore margins across Medicaid, Medicare and Marketplace.
Centene's mix of business shifted this quarter. Marketplace membership fell to 3,494,700 from 5,862,800 a year earlier as pricing was reset to address member acuity. Medicare Prescription Drug Plan membership grew to 8,803,000, and Medicaid membership declined to 12,110,700. Medicare Advantage is moving toward duals, and CMS's move to D-SNP-based integration put former Medicare-Medicaid Plan members into the Medicare line. Commercial group and ICHRA membership grew to 497,000.
Management says it is leaning in to transform the organization, and long-term differentiation will increasingly come from proprietary data and context. Plans include simplifying the Medicare Advantage footprint and pursuing margin recovery in Medicaid despite federal policy headwinds referred to as OB3. The tension is that margin restoration is coming as membership shrinks in Medicaid and Marketplace, while competition has shifted and enterprise optimization, including a voluntary separation program, must be executed.
No call transcript for this quarter, so this summary also draws on: The Motley Fool ↗.
Key numbers
- Total revenues · GAAP
- $53.6B
- Net earnings attributable to Centene · GAAP
- $1.1B
- GAAP diluted EPS · GAAP
- $2.19
- Adjusted diluted EPS · non-GAAP
- $2.51
- Cash flow provided by operations · GAAP
- $3.6B
| Segment or metric | Value | Change |
|---|---|---|
| Medicaid premium and service revenues | $22.8B | 5% |
| Medicare premium and service revenues | $11.1B | 17% |
| Marketplace membership | 3,494,700 | down from 5,862,800 a year earlier |
| Medicare PDP membership | 8,803,000 | up from 7,845,800 a year earlier |
| Total Medicaid membership | 12,110,700 | down from 12,819,700 a year earlier |
Where each number comes from
- Total revenues: “Total revenues (in millions) | $53,579 Premium and service revenues (in millions) | $44,375 Health benefits ratio | 89.6% SG&A expense ratio | 7.0%”
- Net earnings attributable to Centene: “GAAP net earnings (loss) attributable to Centene | $1,091 | $(253) | $2,632 | $1,058”
- GAAP diluted EPS: “Second Quarter GAAP Diluted Earnings Per Share of $2.19; Adjusted Diluted Earnings Per Share of $2.51”
- Adjusted diluted EPS: “Second Quarter GAAP Diluted Earnings Per Share of $2.19; Adjusted Diluted Earnings Per Share of $2.51”
- Cash flow provided by operations: “Adjusted SG&A expense ratio (1) | 6.9% GAAP diluted earnings per share | $2.19 Adjusted diluted earnings per share (1) | $2.51 Total cash flow provided by operations (in millions) | $3,590”
- Medicaid premium and service revenues: “Medicaid | $22,766 | $21,723 | 5% Commercial | 9,356 | 10,070 | (7)% Medicare (1) | 11,057 | 9,450 | 17% Other | 1,196 | 1,224 | (2)%”
- Medicare premium and service revenues: “Medicaid | $22,766 | $21,723 | 5% Commercial | 9,356 | 10,070 | (7)% Medicare (1) | 11,057 | 9,450 | 17% Other | 1,196 | 1,224 | (2)%”
- Marketplace membership: “Total Medicaid | 12,110,700 | 12,819,700 Marketplace | 3,494,700 | 5,862,800 Individual and Commercial Group (3) | 497,000 | 449,700”
- Medicare PDP membership: “Medicare (4) | 980,000 | 1,026,900 Medicare Prescription Drug Plan (PDP) | 8,803,000 | 7,845,800 Total at-risk membership | 25,885,400 | 28,004,900”
- Total Medicaid membership: “Total Medicaid | 12,110,700 | 12,819,700 Marketplace | 3,494,700 | 5,862,800 Individual and Commercial Group (3) | 497,000 | 449,700”
Copied from the press release ↗ and other documents in the SEC filing ↗. A figure is published only if its sentence is in those documents.
| From the filing | Q2 2026 | vs year ago | vs last quarter |
|---|---|---|---|
| Revenue | $53.6B | +9.9% | +7.3% |
| Operating income | $1.2B | — | −35.6% |
| Net income | $1.1B | — | −29.2% |
| Diluted EPS | $2.19 | — | −29.6% |
| Free cash flow | $3.4B | +116.6% | −18.0% |
| Gross margin | 8.6% | +2.4 pts | −2.7 pts |
| Operating margin | 2.2% | +3.1 pts | −1.5 pts |
Calculated by code from XBRL, not by the model.
Outlook
| Metric | Period | Outlook |
|---|---|---|
| Total revenues | full year 2026 | $193.5 billion to $197.5 billion |
| GAAP diluted EPS | full year 2026 | greater than $3.11 |
| Adjusted diluted EPS | full year 2026 | greater than $4.80 |
| Health benefits ratio | full year 2026 | 90.5% to 91.3% |
Key takeaways
Medicare Advantage is being simplified around duals
Management plans to further simplify its Medicare Advantage footprint and focus benefits increasingly on the duals population. D-SNP members now represent approximately 40% of the Medicare Advantage portfolio.
Marketplace shrank sharply after repricing
Marketplace membership fell to 3,494,700 from 5,862,800 a year earlier. Centene attributes its lower Marketplace cost ratio to improved pricing and risk transfer reflecting the acuity of the membership.
PDP is a growth engine with lower overhead
Medicare PDP membership rose to 8,803,000 from 7,845,800 a year earlier. Centene says PDP operates at a meaningfully lower SG&A expense ratio than the company overall, so its growth helps efficiency.
Medicaid goal is margin recovery despite OB3 headwinds
Management says its goal remains margin recovery for Medicaid even through the OB3 headwinds. Medicaid membership fell to 12,110,700 as high acuity membership dropped, and management says the competitive landscape has changed slightly.
Enterprise optimization and data are central to strategy
Centene describes leaning in to transform the organization, with long-term differentiation coming increasingly from proprietary data and context. Its 2026 plan includes a voluntary separation program, and employees fell to 59,800 from 61,000 last quarter.
Charts
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $40.8B * |
| Q1 2025 | $46.6B |
| Q2 2025 | $48.7B |
| Q3 2025 | $49.7B |
| Q4 2025 | $49.7B * |
| Q1 2026 | $49.9B |
| Q2 2026 | $53.6B |
| Q3 2026 | $50.6B |
Data
| Q1 2025 | $2.63 |
| Q2 2025 | -$0.51 |
| Q3 2025 | -$13.50 |
| Q1 2026 | $3.11 |
| Q2 2026 | $2.19 |
| Q3 2026 | -$0.14 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q4 2024 | 0.4% |
| Q1 2025 | 3.3% |
| Q2 2025 | -0.9% |
| Q3 2025 | -14.0% |
| Q4 2025 | -3.5% |
| Q1 2026 | 3.7% |
| Q2 2026 | 2.2% |
| Q3 2026 | -0.6% |
Data
| Q4 2024 | -$741.0M |
| Q1 2025 | $1.4B |
| Q2 2025 | $1.6B |
| Q3 2025 | $1.1B |
| Q4 2025 | $224.0M |
| Q1 2026 | $4.2B |
| Q2 2026 | $3.4B |
| Q3 2026 | -$3.9B |
Operating cash flow minus capital expenditure, from cash flow statements.
Questions
How is Centene changing its Medicare Advantage business?
It plans to further simplify its Medicare Advantage footprint and focus benefits increasingly on the duals population. D-SNP members now represent approximately 40% of the Medicare Advantage portfolio.
What happened to Centene's Marketplace business?
Marketplace membership dropped to 3,494,700 from 5,862,800 a year earlier. Centene says improved pricing and risk transfer reflecting member acuity lowered the Marketplace cost ratio.
Which Centene lines are growing in membership?
Medicare PDP grew to 8,803,000 members from 7,845,800 a year earlier, and Individual and Commercial Group rose to 497,000 from 449,700. Medicaid and Marketplace membership both declined.
What is management's plan for Medicaid?
Management says its goal remains margin recovery for the Medicaid business even through the OB3 headwinds. Medicaid membership fell to 12,110,700 from 12,819,700.
What is Centene's broader strategic direction?
Management says it is leaning in to transform the organization and expects long-term differentiation to come increasingly from proprietary data and context. It is also running enterprise optimization, including a voluntary separation program.
Documents
SEC filing